Scarlight MD

Manufacturer
Scarguard Labs, LLC
Effective date
2009-12-29
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 22:23:08

Label at a glance#

ProductScarlight MD
Active ingredientHYDROQUINONE
Label structure14 sections

Indications and uses

lightens dark (brownish) discoloration in the skin such as age and liver spots

Dosage and administration

adults: brush a small amount twice daily. Rub in. limit sun exposure and use a sunscreen, a sun blocking agent or protective clothing to cover bleached skin when using and after using this product in order to prevent darkening from reoccurring discontinue if symptoms persist for more than 3 months children under 12 years of age, consult a doctor before use

Storage and handling

store at 15º to 30ºC (59 to 86ºF) keep bottle tightly closed or product will evaporate

Label contents#

Full prescribing information#

Active Ingredients

OTC - ACTIVE INGREDIENT SECTION

Hydroquinone 2%

Purpose

OTC - PURPOSE SECTION

Skin Lightener

Uses

INDICATIONS & USAGE SECTION

  • lightens dark (brownish) discoloration in the skin such as age and liver spots

Warnings

WARNINGS AND PRECAUTIONS SECTION

For external use only

Do not use

OTC - DO NOT USE SECTION

  • on children under 12 years of age.  Consult a doctor.
  • on mucous membranes

When using this product

OTC - WHEN USING SECTION

  • mild irritation may occur
  • avoid contact with eyes.  If contact occurs, rinse with water.

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • irritation becomes severe
  • condition worsens

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • adults: brush a small amount twice daily. Rub in.
  • limit sun exposure and use a sunscreen, a sun blocking agent or protective clothing to cover bleached skin when using and after using this product in order to prevent darkening from reoccurring
  • discontinue if symptoms persist for more than 3 months
  • children under 12 years of age, consult a doctor before use

Other Information

STORAGE AND HANDLING SECTION

  • store at 15º to 30ºC (59 to 86ºF)
  • keep bottle tightly closed or product will evaporate

Inactive Ingredients

INACTIVE INGREDIENT SECTION

retinoic acid, melatonin, MSM, BHT, na metabisulfite, arbutin, cystamine, licorice root, dandelion root, hydroxyanisole, ascorbic acid, hydroxypropylcellulose, kojic acid, azelaic acid, acetone, propylene glycol, ethyl alcohol (SDA), distilled water q.s.

Questions

OTC - QUESTIONS SECTION

call

1-877-566-5935

Carton 15mL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

15mL Label15mL Label

Carton 30mL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

30mL Label30mL Label

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
HYDROQUINONE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
b80ad7bc-1b6f-7ef4-1ed0-86cd9f459d60Product name620251124
1426d8f8-b7d5-4053-8554-613df00c0d86Product name220250616
0e7b8bf1-c46c-4de6-b26a-0c50e34364ecProduct name220250521
e3af9708-3004-7392-4046-5311eaa8bab5Product name320221128
13e7e7e3-e885-4c79-af6d-dad1aedbb06eProduct name120220128
6c6fc281-9445-2e9e-1c29-a09ddbc4299cProduct name220200213
503b047e-e62d-4745-9011-522b13bc701bProduct name120181206
7d41caa2-0b5d-9b03-ab8d-84271de26ef4Product name220170314
50ca9ff5-82dd-9971-4f2c-5845a76a8572Product name220150818
2a856070-cbe7-4f85-be0f-09885ff91196Product name120150806
0a8118e4-08c6-b395-9ddc-d3e425e0493aProduct name120140508
233bcb0a-cf40-b0a1-b346-c83ac2f43579Product name120140508
85490a6b-2306-6bf2-c51b-eb63537dc2daProduct name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
64269-9902-72020-01-31C16284748780-19d75b9d1-0c5d-f424-e053-dadaa90a57ceDrug Facts
64269-9902-82020-01-31C16284748780-19d75b9d1-0c5d-f424-e053-dadaa90a57ceDrug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
64269-9902-7Scarlight MD15 mL in 1 BOTTLE, WITH APPLICATORLIQUID151
64269-9902-8Scarlight MD30 mL in 1 BOTTLE, WITH APPLICATORLIQUID301

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
64269-9902SCARLIGHT MD (HYDROQUINONE) LIQUID [SCARGUARD LABS, LLC]1Legacy NDC, 2 package rows20091230_c24a9fd8-1fb5-4643-92df-b268479a35e5.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
HYDROQUINONEACTIVE INGREDIENTXV74C1N1AE1
HydroquinoneACTIVE MOIETYXV74C1N1AE1
AcetoneINACTIVE INGREDIENT1364PS73AF1
AlcoholINACTIVE INGREDIENT3K9958V90M1
ArbutinINACTIVE INGREDIENTC5INA23HXF1
Ascorbic AcidINACTIVE INGREDIENTPQ6CK8PD0R1
Azelaic AcidINACTIVE INGREDIENTF2VW3D43YT1
Butylated HydroxyanisoleINACTIVE INGREDIENTREK4960K2U1
Butylated HydroxytolueneINACTIVE INGREDIENT1P9D0Z171K1
CystamineINACTIVE INGREDIENTR110LV8L021
Dimethyl SulfoneINACTIVE INGREDIENT9H4PO4Z4FT1
Hydroxypropyl CelluloseINACTIVE INGREDIENTRFW2ET671P1
Kojic AcidINACTIVE INGREDIENT6K23F1TT521
LicoriceINACTIVE INGREDIENT61ZBX548831
MelatoninINACTIVE INGREDIENTJL5DK93RCL1
Propylene GlycolINACTIVE INGREDIENT6DC9Q167V31
Sodium MetabisulfiteINACTIVE INGREDIENT4VON5FNS3C1
TARAXACUM OFFICINALE ROOTINACTIVE INGREDIENT9DE5YCO0RU1
TretinoinINACTIVE INGREDIENT5688UTC01R1
WaterINACTIVE INGREDIENT059QF0KO0R1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 20 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
64269-990264269-9902-8, 64269-9902-7

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 19 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 5 · 292 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
Sodium MetabisulfiteSODIUM METABISULFITE4VON5FNS3CINJECTION, SOLUTION, CONCENTRATE / SUBCUTANEOUS0.15 %w/vExact identifier — unii candidate
43 equally ranked IID candidates
Ascorbic AcidASCORBIC ACIDPQ6CK8PD0RTABLET, ORALLY DISINTEGRATING / ORAL2.35 mgExact identifier — unii candidate
25 equally ranked IID candidates
Propylene GlycolPROPYLENE GLYCOL6DC9Q167V3DROPS / ORAL200 mg/1mlExact identifier — unii candidate
81 equally ranked IID candidates
Butylated HydroxytolueneBUTYLATED HYDROXYTOLUENE1P9D0Z171KFILM, SOLUBLE / ORAL0.06 mgExact identifier — unii candidate
32 equally ranked IID candidates
AlcoholALCOHOL3K9958V90MLIQUID / ORAL3563 mgExact identifier — unii candidate
59 equally ranked IID candidates
Propylene GlycolPROPYLENE GLYCOL6DC9Q167V3TABLET, COATED / ORAL16 mgExact identifier — unii candidate
81 equally ranked IID candidates
Propylene GlycolPROPYLENE GLYCOL6DC9Q167V3FILM, SOLUBLE / BUCCAL5 mgExact identifier — unii candidate
81 equally ranked IID candidates
Propylene GlycolPROPYLENE GLYCOL6DC9Q167V3CREAM / TOPICAL76000 mgExact identifier — unii candidate
81 equally ranked IID candidates
AlcoholALCOHOL3K9958V90MAEROSOL, METERED / RESPIRATORY (INHALATION)26664 mgExact identifier — unii candidate
59 equally ranked IID candidates
Propylene GlycolPROPYLENE GLYCOL6DC9Q167V3OINTMENT, AUGMENTED / TOPICAL714 mgExact identifier — unii candidate
81 equally ranked IID candidates
Ascorbic AcidASCORBIC ACIDPQ6CK8PD0RCAPSULE / ORAL7 mgExact identifier — unii candidate
25 equally ranked IID candidates
Butylated HydroxytolueneBUTYLATED HYDROXYTOLUENE1P9D0Z171KINJECTION, SOLUTION / INTRAVENOUSNAExact identifier — unii candidate
32 equally ranked IID candidates
Butylated HydroxytolueneBUTYLATED HYDROXYTOLUENE1P9D0Z171KCREAM / VAGINAL0.05 %w/wExact identifier — unii candidate
32 equally ranked IID candidates
Propylene GlycolPROPYLENE GLYCOL6DC9Q167V3SOLUTION/ DROPS / AURICULAR (OTIC)ADJ PHExact identifier — unii candidate
81 equally ranked IID candidates
Butylated HydroxyanisoleBUTYLATED HYDROXYANISOLEREK4960K2UCAPSULE, LIQUID FILLED / ORAL4 mgExact identifier — unii candidate
24 equally ranked IID candidates
Sodium MetabisulfiteSODIUM METABISULFITE4VON5FNS3CSUSPENSION / TOPICAL0.32 %w/vExact identifier — unii candidate
43 equally ranked IID candidates
Propylene GlycolPROPYLENE GLYCOL6DC9Q167V3SOLUTION, CONCENTRATE / INTRAVENOUS50.33 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
Butylated HydroxyanisoleBUTYLATED HYDROXYANISOLEREK4960K2USYRUP / ORAL1 mgExact identifier — unii candidate
24 equally ranked IID candidates
Ascorbic AcidASCORBIC ACIDPQ6CK8PD0RSUSPENSION, EXTENDED RELEASE / ORAL6 mgExact identifier — unii candidate
25 equally ranked IID candidates
Sodium MetabisulfiteSODIUM METABISULFITE4VON5FNS3CINJECTION / SUBMUCOSAL5 mgExact identifier — unii candidate
43 equally ranked IID candidates
Hydroxypropyl CelluloseHYDROXYPROPYL CELLULOSE (1600000 WAMW)RFW2ET671PLOTION, AUGMENTED / TOPICAL0.2 %w/wExact identifier — unii candidate
27 equally ranked IID candidates
Sodium MetabisulfiteSODIUM METABISULFITE4VON5FNS3CINJECTION / INTRACARDIAC0.09 %w/vExact identifier — unii candidate
43 equally ranked IID candidates
Propylene GlycolPROPYLENE GLYCOL6DC9Q167V3SOLUTION / TOPICAL4886 mgExact identifier — unii candidate
81 equally ranked IID candidates
Butylated HydroxyanisoleBUTYLATED HYDROXYANISOLEREK4960K2UINJECTION / INTRAVENOUSNAExact identifier — unii candidate
24 equally ranked IID candidates
Propylene GlycolPROPYLENE GLYCOL6DC9Q167V3SUSPENSION / TOPICAL5.28 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
Propylene GlycolPROPYLENE GLYCOL6DC9Q167V3EMULSION / TOPICAL8 %w/wExact identifier — unii candidate
81 equally ranked IID candidates
Propylene GlycolPROPYLENE GLYCOL6DC9Q167V3SUSPENSION / RECTAL90400 mgExact identifier — unii candidate
81 equally ranked IID candidates
Ascorbic AcidASCORBIC ACIDPQ6CK8PD0RSUPPOSITORY / RECTAL3 mgExact identifier — unii candidate
25 equally ranked IID candidates
Propylene GlycolPROPYLENE GLYCOL6DC9Q167V3SUSPENSION, EXTENDED RELEASE / ORAL1000 mgExact identifier — unii candidate
81 equally ranked IID candidates
Hydroxypropyl CelluloseHYDROXYPROPYL CELLULOSE (1600000 WAMW)RFW2ET671PTABLET, DELAYED RELEASE / ORAL450 mgExact identifier — unii candidate
27 equally ranked IID candidates
Propylene GlycolPROPYLENE GLYCOL6DC9Q167V3SUSPENSION / AURICULAR (OTIC)10 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
Butylated HydroxytolueneBUTYLATED HYDROXYTOLUENE1P9D0Z171KTABLET / SUBLINGUAL0.13 mgExact identifier — unii candidate
32 equally ranked IID candidates
Sodium MetabisulfiteSODIUM METABISULFITE4VON5FNS3CINJECTION / EPIDURAL0.05 %w/vExact identifier — unii candidate
43 equally ranked IID candidates
Ascorbic AcidASCORBIC ACIDPQ6CK8PD0RINJECTION, POWDER, FOR SOLUTION / INTRAVENOUS2 mgExact identifier — unii candidate
25 equally ranked IID candidates
Propylene GlycolPROPYLENE GLYCOL6DC9Q167V3SOLUTION, CONCENTRATE / ORAL2590 mgExact identifier — unii candidate
81 equally ranked IID candidates
Butylated HydroxyanisoleBUTYLATED HYDROXYANISOLEREK4960K2UCAPSULE / ORAL4 mgExact identifier — unii candidate
24 equally ranked IID candidates
Sodium MetabisulfiteSODIUM METABISULFITE4VON5FNS3CSUSPENSION, EXTENDED RELEASE / ORAL100 mgExact identifier — unii candidate
43 equally ranked IID candidates
AlcoholALCOHOL3K9958V90MSOLUTION / TRANSDERMAL49.37 %w/vExact identifier — unii candidate
59 equally ranked IID candidates
Sodium MetabisulfiteSODIUM METABISULFITE4VON5FNS3CTABLET / ORAL8 mgExact identifier — unii candidate
43 equally ranked IID candidates
Sodium MetabisulfiteSODIUM METABISULFITE4VON5FNS3CINJECTION, SOLUTION / SUBCUTANEOUS79 mgExact identifier — unii candidate
43 equally ranked IID candidates
AlcoholALCOHOL3K9958V90MSOLUTION, CONCENTRATE / INTRAVENOUS4000 mgExact identifier — unii candidate
59 equally ranked IID candidates
Butylated HydroxytolueneBUTYLATED HYDROXYTOLUENE1P9D0Z171KLOTION / TOPICAL1000 mgExact identifier — unii candidate
32 equally ranked IID candidates
Butylated HydroxytolueneBUTYLATED HYDROXYTOLUENE1P9D0Z171KSOAP / TOPICAL0.02 %w/wExact identifier — unii candidate
32 equally ranked IID candidates
Propylene GlycolPROPYLENE GLYCOL6DC9Q167V3SHAMPOO / TOPICAL8 %w/wExact identifier — unii candidate
81 equally ranked IID candidates
AlcoholALCOHOL3K9958V90MSUSPENSION / RECTAL0.35 %v/vExact identifier — unii candidate
59 equally ranked IID candidates
Propylene GlycolPROPYLENE GLYCOL6DC9Q167V3INJECTION / SUBCUTANEOUS1.4 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
AlcoholALCOHOL3K9958V90MAEROSOL, SPRAY / RESPIRATORY (INHALATION)35.75 %w/wExact identifier — unii candidate
59 equally ranked IID candidates
Propylene GlycolPROPYLENE GLYCOL6DC9Q167V3GEL / TOPICAL4522 mgExact identifier — unii candidate
81 equally ranked IID candidates
Propylene GlycolPROPYLENE GLYCOL6DC9Q167V3SOLUTION / RESPIRATORY (INHALATION)25 %w/wExact identifier — unii candidate
81 equally ranked IID candidates
Hydroxypropyl CelluloseHYDROXYPROPYL CELLULOSE (1600000 WAMW)RFW2ET671PSUSPENSION / ORAL100 mgExact identifier — unii candidate
27 equally ranked IID candidates
Sodium MetabisulfiteSODIUM METABISULFITE4VON5FNS3CSYRUP / ORAL80 mgExact identifier — unii candidate
43 equally ranked IID candidates
Propylene GlycolPROPYLENE GLYCOL6DC9Q167V3FILM, EXTENDED RELEASE / TRANSDERMAL58.13 mgExact identifier — unii candidate
81 equally ranked IID candidates
AlcoholALCOHOL3K9958V90MCONCENTRATE / ORAL198 mgExact identifier — unii candidate
59 equally ranked IID candidates
Ascorbic AcidASCORBIC ACIDPQ6CK8PD0RINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS1440 mgExact identifier — unii candidate
25 equally ranked IID candidates
Butylated HydroxytolueneBUTYLATED HYDROXYTOLUENE1P9D0Z171KGEL / TOPICAL8 mgExact identifier — unii candidate
32 equally ranked IID candidates
AlcoholALCOHOL3K9958V90MSOLUTION / ORAL6624 mgExact identifier — unii candidate
59 equally ranked IID candidates
Butylated HydroxyanisoleBUTYLATED HYDROXYANISOLEREK4960K2ULOTION / TOPICALNAExact identifier — unii candidate
24 equally ranked IID candidates
Sodium MetabisulfiteSODIUM METABISULFITE4VON5FNS3CSUSPENSION / ORAL40 mgExact identifier — unii candidate
43 equally ranked IID candidates
Ascorbic AcidASCORBIC ACIDPQ6CK8PD0RAEROSOL, METERED / RESPIRATORY (INHALATION)0.1 %w/wExact identifier — unii candidate
25 equally ranked IID candidates
AlcoholALCOHOL3K9958V90MGEL / DENTAL1.8 %w/wExact identifier — unii candidate
59 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ad6d99fb-9b13-47d5-b0ed-b2312b2b1274c24a9fd8-1fb5-4643-92df-b268479a35e52009-12-29WarningsExact identifier
spl id: ad6d99fb-9b13-47d5-b0ed-b2312b2b1274
spl set id: c24a9fd8-1fb5-4643-92df-b268479a35e5

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.